Swaraj Shares and Securities Private Limited ("Manager to the Offer") has submitted to BSE a copy of Post-Offer Public Announcement to the Public Shareholders of Chemo Pharma Laboratories ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Manager to the Offer Swaraj Shares & Securities has submitted to BSE the Post-Offer Public Announcement for an open offer made by Atibha Agriseeds Private Limited (Acquirer) to acquire up to 3,90,000 shares (26.00% of voting share capital) from public shareholders of Chemo Pharma Laboratories Limited at an offer price of ₹110 per share, aggregating to ₹4.29 crore. The offer was triggered under SEBI (SAST) Regulations pursuant to a Share Purchase Agreement dated February 18, 2025, under which the Acquirer bought 4,18,281 shares (27.89%) from promoters Citric India Limited and Shanta Somani at ₹100 per share. The Post-Offer Advertisement was published on June 19, 2025, in Financial Express, Jansatta, and Mumbai Lakshadeep newspapers.
Public shareholders of Chemo Pharma Laboratories now have clarity on the concluded open offer timeline and pricing; the offer price of ₹110 represents a 10% premium over the underlying SPA price of ₹100 paid to promoters, indicating the minimum exit opportunity offered to public investors.